Post-operative pain (POP) is endured by millions every day all over the world and its effective relief is very important and necessary (
1,
2). POP imposes additional costs on the health care system every year and it is an important aspect considered in the healthcare process (
3,
4). Inappropriate pain management in different settings, from the emergency department to the operating room and afterward, has been documented in the current literature and research regarding better approach is still ongoing (
5-
8). The efficient management of POP is currently a part of surgery process and reduces patients’ morbidity as well as their mortality, accelerates recovery and discharge from the hospital, improves patients’ quality of life, and reduces costs. The efficient management of POP includes a multimodal approach during which various drugs with different mechanisms and administration routes are used. One of the aspects considered in this regard is the social history of the patient. A history of drug abuse is one of the most important things that should be recorded in patients’ medical profile since opium addict patients make up a large portion of hospital visitors and obviously, their pain threshold and need for analgesia are different (
9-
11). Addiction is an international problem and one of the healthcare problems in various societies and there may be only a few countries not having this issue. Addiction is one of the 4 major crises that has caused serious harm to at least 200 million people around the world (
9,
10,
12). The prevalence of drug abuse such as opioid use is on the rise, and a considerable percentage of opioid-addict patients are admitted for surgery. Some authors believe that these patients can be expected to the experience of increased postoperative pain, greater postoperative opioid consumption, and prolonged use of healthcare resources for managing their pain (
13). Dexmedetomidine (Dex) is one of the drugs considered for POP in opium addict patients in recent studies. This drug is a highly selective α2-adrenergic and has been used as an analgesic along with other anesthetic drugs for reducing POP in opium-addict patients (
14). Achieving adequate pain control in opioid addict patients can be challenging because commonly used strategies for alleviating postoperative pain may have diminished effectiveness (
13). There are limited available scientific sources of data and rare controlled studies to guide the anesthesiologist regarding preoperative analgesic care in opioid addict patients, despite the increasing prevalence of opioid dependence (
15).